Abstract
No public abstract is available from the verified source records.
Contact and support
Need help, have a question, or want to contact the ResearchHub team?
© 2026 ResearchHub. Built for responsible scholarly connection.
Privacy-aware community infrastructureAbstract
Authors
Institutions
No ROR-resolved institution is linked to this work yet.
Provenance
crossref
Confidence 100%
pubmed
Confidence 98%
europepmc
Confidence 96%
unpaywall
Confidence 95%
datacite
Confidence 0%
No local reference links have been materialized yet.
No local citing links have been materialized yet.
Histologic features and clinical outcomes of lean metabolic dysfunction–associated steatotic liver disease.
2026
A multisociety Delphi consensus statement on new fatty liver disease nomenclature.
10.1097/hep.0000000000000520 · 2023
Increased risk of mortality by fibrosis stage in nonalcoholic fatty liver disease: systematic review and meta-analysis.
10.1002/hep.29085 · 2017
Metabolic (dysfunction)-associated fatty liver disease in individuals of normal weight.
10.1038/s41575-022-00635-5 · 2022
Caucasian lean subjects with non-alcoholic fatty liver disease share long-term prognosis of non-lean: time for reappraisal of BMI-driven approach?
10.1136/gutjnl-2020-322564 · 2022
Global prevalence, incidence, and outcomes of non-obese or lean non-alcoholic fatty liver disease: a systematic review and meta-analysis.
10.1016/s2468-1253(20)30077-7 · 2020
No additional external references are available.